CVS:NYE-CVS Health Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 67.46

Change

0.00 (0.00)%

Market Cap

N/A

Volume

7.56M

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-15 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 268.12B
ELV Elevance Health Inc

N/A

USD 84.11B
CNC Centene Corp

N/A

USD 28.07B
MOH Molina Healthcare Inc

N/A

USD 16.54B
OSCR Oscar Health Inc

N/A

USD 4.46B
NEUE NeueHealth Inc

N/A

USD 0.06B
CI Cigna Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CVS

FHI-B:CA CI Health Care Giants Cov.. 5.11 % 0.00 %

N/A

CAD 0.05B
XFVT:XETRA Xtrackers - FTSE Vietnam .. 4.04 % 0.00 %

N/A

N/A
GEND Spinnaker ETF Series 3.79 % 0.00 %

N/A

N/A
FMTM MarketDesk Focused U.S. M.. 3.37 % 0.00 %

N/A

N/A
FXG First Trust Consumer Stap.. 3.35 % 0.64 %

N/A

USD 0.30B
UINC:LSE First Trust US Equity Inc.. 3.22 % 0.00 %

N/A

USD 0.31B
UNCU:LSE First Trust US Equity Inc.. 3.19 % 0.00 %

N/A

USD 0.03B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.92 % 0.00 %

N/A

USD 0.15B
ZPD3:XETRA SPDR® S&P® Global Divid.. 2.80 % 0.00 %

N/A

USD 0.02B
ESN Essential 40 Stock ETF 2.73 % 0.00 %

N/A

USD 0.09B
UVAL:LSE SPDR® MSCI USA Value UCI.. 2.72 % 0.00 %

N/A

USD 0.15B
USVL:LSE SPDR® MSCI USA Value UCI.. 2.72 % 0.00 %

N/A

USD 0.15B
GEDV:LSE SPDR® S&P® Global Divid.. 2.70 % 0.00 %

N/A

USD 0.02B
IUVL:SW iShares Edge MSCI USA Val.. 2.20 % 0.00 %

N/A

USD 2.04B
GLDV:SW SPDR® S&P Global Dividen.. 2.02 % 0.00 %

N/A

USD 1.18B
GLDVD:SW UBS (Irl) ETF plc - S&P D.. 1.85 % 0.00 %

N/A

USD 0.11B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

N/A

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

N/A

USD 0.08B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

N/A

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

N/A
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

N/A

N/A
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.42B
XDEW:SW 0.26 % 0.00 %

N/A

N/A
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

N/A

USD 0.77B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

N/A

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.10B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

N/A

USD 0.59B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

N/A

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

N/A

USD 1.14B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

N/A

USD 0.10B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.10B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

N/A

USD 2.50B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

N/A

USD 2.81B
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

N/A

USD 2.25B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
ZVU:CA BMO MSCI USA Value ETF 0.00 % 0.33 %

N/A

CAD 0.06B
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

N/A

USD 0.07B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
UBUM:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

N/A

USD 0.12B
ZPRG:F SPDR S&P Global Dividend .. 0.00 % 0.00 %

N/A

USD 1.04B
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
ZPRU:XETRA SPDR MSCI USA Value UCITS.. 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.28% 100% F 97% N/A
Dividend Return 2.96% 100% F 79% B-
Total Return 53.24% 100% F 97% N/A
Trailing 12 Months  
Capital Gain 12.02% 89% A- 75% C
Dividend Return 4.42% 100% F 69% C-
Total Return 16.44% 89% A- 78% C+
Trailing 5 Years  
Capital Gain 2.87% 50% F 39% F
Dividend Return 17.70% 100% F 51% F
Total Return 20.57% 67% D+ 35% F
Average Annual (5 Year Horizon)  
Capital Gain -2.04% 33% F 27% F
Dividend Return 0.55% 44% F 28% F
Total Return 2.59% 100% F 57% F
Risk Return Profile  
Volatility (Standard Deviation) 28.72% 22% F 31% F
Risk Adjusted Return 1.93% 44% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector